Fundalysisby DARKHORSESTOCKS

Stock · US02043Q1076

Alnylam Pharmaceuticals Inc

Held by 2 schemes worth ₹25 Cr in Sept 2026.

Schemes holding Alnylam Pharmaceuticals Inc(Feb 2021 – Sept 2026)

Schemes holding Alnylam Pharmaceuticals Inc in Sept 2026. Tick up to 2 to plot them.
Plot2 schemes · ₹ Cr
Motilal Oswal Nasdaq 100 ETF
19.9
ICICI Prudential Nasdaq 100 Index Fund
5.2
  • Motilal Oswal Nasdaq 100 ETF
  • ICICI Prudential Nasdaq 100…
Market value of Alnylam Pharmaceuticals Inc in each ticked scheme, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
MonthMotilal Oswal Nasdaq 100 ETFICICI Prudential Nasdaq 100 Index Fund
Sept 2025₹0 Cr₹0 Cr
Oct 2025₹0 Cr₹0 Cr
Nov 2025₹0 Cr₹0 Cr
Dec 2025₹32.4 Cr₹7.6 Cr
Jan 2026₹27.4 Cr₹6.5 Cr
Feb 2026₹26.6 Cr₹6.6 Cr
Mar 2026₹27.2 Cr₹6.9 Cr
Apr 2026₹25.6 Cr₹6.5 Cr
May 2026₹24.9 Cr₹6.4 Cr
Jun 2026₹24.6 Cr₹6.3 Cr
Jul 2026₹16.8 Cr₹4.3 Cr
Aug 2026₹19.6 Cr₹5.1 Cr
Sept 2026₹19.9 Cr₹5.2 Cr
Fig. 1.Market value of Alnylam Pharmaceuticals Inc in each ticked scheme, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Allocation(Sept 2026)

Fund houses

2 fund houses% of total
Motilal Oswal
179.35
ICICI
120.65

Scheme types

Schemes

Fig. 2.What mutual funds hold of this company, by fund house, by scheme type and by scheme. Hover a slice or a row; click a slice to open it.

Schemes buying and selling Alnylam Pharmaceuticals Inc(Oct 2025 – Sept 2026)

Schemes buying and selling Alnylam Pharmaceuticals Inc. Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.